Alnylam Pharmaceuticals, Inc. financial data

Symbol
ALNY on Nasdaq
Industry
Pharmaceutical Preparations
Location
675 West Kendall Street, Henri A. Termeer Square, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 299 % -11.6%
Quick Ratio 8.2 % -43%
Debt-to-equity -3.96K % -159%
Return On Equity 324 % +57.3%
Return On Assets -8.38 % +41.8%
Operating Margin -75.7 % +9.84%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 129M shares +2.78%
Common Stock, Shares, Outstanding 129M shares +2.7%
Entity Public Float 23.7B USD +34.4%
Common Stock, Value, Issued 1.29M USD +2.71%
Weighted Average Number of Shares Outstanding, Basic 129M shares +2.69%
Weighted Average Number of Shares Outstanding, Diluted 129M shares -2.09%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.04B USD +22.9%
Revenue from Contract with Customer, Excluding Assessed Tax 2.09B USD +21.5%
Research and Development Expense 1.1B USD +10.4%
Costs and Expenses 2.28B USD +9.86%
Operating Income (Loss) -188M USD +46.9%
Nonoperating Income (Expense) -133M USD +10.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -321M USD +36.1%
Income Tax Expense (Benefit) 11.2M USD +59.1%
Net Income (Loss) Attributable to Parent -332M USD +34.8%
Earnings Per Share, Basic -2.61 USD/shares +36.7%
Earnings Per Share, Diluted -2.58 USD/shares +37.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.1B USD +6.48%
Accounts Receivable, after Allowance for Credit Loss, Current 354M USD +8.73%
Inventory, Net 76M USD -20.7%
Assets, Current 3.36B USD +12.4%
Property, Plant and Equipment, Net 507M USD -3.54%
Operating Lease, Right-of-Use Asset 196M USD -3.48%
Other Assets, Noncurrent 77.6M USD +3.28%
Assets 4.21B USD +9.53%
Accounts Payable, Current 70.8M USD -4.11%
Employee-related Liabilities, Current 122M USD -6.52%
Accrued Liabilities, Current 946M USD +32.7%
Contract with Customer, Liability, Current 71M USD -7.92%
Liabilities, Current 1.22B USD +28.5%
Contract with Customer, Liability, Noncurrent 1.01M USD -99.5%
Operating Lease, Liability, Noncurrent 236M USD -4.72%
Other Liabilities, Noncurrent 357M USD +27.3%
Liabilities 4.17B USD +4.19%
Accumulated Other Comprehensive Income (Loss), Net of Tax -24.8M USD +23.2%
Retained Earnings (Accumulated Deficit) -7.2B USD -4.84%
Stockholders' Equity Attributable to Parent 32.4M USD
Liabilities and Equity 4.21B USD +9.53%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -81.5M USD +51%
Net Cash Provided by (Used in) Financing Activities 28.9M USD -37.7%
Net Cash Provided by (Used in) Investing Activities -67.6M USD +11.3%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 129M shares +2.7%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -130M USD +33%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.1B USD +6.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 30.9M USD +122%
Deferred Tax Assets, Valuation Allowance 2.82B USD +28.4%
Deferred Tax Assets, Gross 2.9B USD +26.3%
Operating Lease, Liability 285M USD -6.16%
Payments to Acquire Property, Plant, and Equipment 13M USD -6.61%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -325M USD +34.8%
Lessee, Operating Lease, Liability, to be Paid 418M USD -9.15%
Property, Plant and Equipment, Gross 749M USD +7.49%
Operating Lease, Liability, Current 42.1M USD +1.51%
Lessee, Operating Lease, Liability, to be Paid, Year Two 46.4M USD -0.25%
Lessee, Operating Lease, Liability, to be Paid, Year One 43.6M USD +1.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 133M USD -14.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 40.6M USD -5.18%
Deferred Tax Assets, Operating Loss Carryforwards 803M USD 0%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 39M USD -3.39%
Operating Lease, Payments 10.7M USD +17.8%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 222M USD -0.01%
Interest Expense 128M USD -10.6%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%